CMS Open Payments data for 2014 is now available and includes information on 11.4 million financial transactions attributed to over 600,000 physicians and more than 1100 teaching hospitals, totaling $6.49 billion.
Data on transfer of value by drug and medical device makers to healthcare providers from 2014 are now available on CMS' Open Payments. The data includes information on 11.4 million financial transactions attributed to over 600,000 physicians and more than 1100 teaching hospitals, totaling $6.49 billion.
CMS has validated 98.8% of all records submitted in the Open Payments system for 2013 and 2014. Records that could not be verified were rejected and not processed.
“Consumer access to information is a key component of delivery system reform and making the healthcare system perform better," Acting CMS Administrator Andy Slavitt, said in a statement. "In year 2, Open Payments is now a highly searchable resource to provide transparency to over 1-and-a-half years’ worth of financial transactions between drug and device companies and physicians and teaching hospitals. This is part of our larger effort to open up the healthcare system to consumers by providing more information to help in their decision making.”
While the American Medical Association (AMA) applauds CMS' efforts of transparency, it experssed concern that the majority of information released through Open Payments was not independently validated by physicians. In addition, the Association pointed out that the process for physicians to review their data and seek to correct any inaccuracies is complicated and cumbersome.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More